September 21, 2020

The Niche

Knoepfler lab stem cell blog

Pulmonary disease

5 min read

Washington Post reporters William Wan and Laurie McGinley have a new piece on the unproven regenerative clinic firm the Lung Health Institute. This article has a number of surprises and new insights. Previously the Lung Health Institute was called just the Lung Institute. It was recently acquired by the publicly-traded company H-CYTE, stock symbol HCYT. In the past they marketed stem cells for various pulmonary diseases included COPD. Now it appears they are primarily marketing a form of platelet-rich plasma (PRP), which the company claims in …Read More

3 min read

Where do things stand today for using stem cells to treat COPD? Chronic obstructive pulmonary disease (COPD) is a relatively common, often debilitating illness, which has a major impact on the people of the world. In the US alone, COPD costs the country almost $50 billion a year not to mention untold suffering. Most of us know someone who has COPD, which is an umbrella term that includes chronic bronchitis and emphysema. Researchers are still investigating the causes, but two big ones are smoking …Read More

3 min read

Chronic obstructive pulmonary disease (COPD) is a relatively common, often debilitating illness, which has a major impact on the people of the world. In the U.S. alone, COPD costs the country almost $50 billion a year not to  mention untold suffering. Most of us know someone who has COPD. COPD is an umbrella term that includes chronic bronchitis and emphysema. Researchers are still investigating the causes, but two big ones are smoking and pollution. There are a number of treatments for COPD, but no …Read More